MedTrace Logo

Switchability Study Between Brand and Generic Topiramate

NCT02113787 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2021-09-29

No results posted yet for this study

Summary

The purpose of the study is to prove the bioequivalence of brand and generic topiramate.

Conditions

Interventions

PROCEDURE

Pharmacokinetic study

Patients who are examen pharmacokinetic study after taking Topamax or Topiramate during 7 days

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Kon Chu, MD, PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2017-03-31
Completion
2017-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02113787 on ClinicalTrials.gov